Relmada Therapeutics (RLMD) Notes Payables (2014 - 2019)
Relmada Therapeutics (RLMD) reported Notes Payables of $110247.0 for Q4 2019, down 3.88% year-over-year from $114700.0 in Q4 2018, and down 56.92% on a QoQ basis from $255925.0 in Q3 2019.
Relmada Therapeutics (RLMD) has 6 years of Notes Payables data on file, last reported at $110247.0 in Q4 2019.
- Quarterly Notes Payables fell 3.88% year-over-year to $110247.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $110247.0 (down 3.88% YoY) and the FY2019 annual result came in at $110247.0, changed N/A from the prior year.
- Notes Payables retreated to $110247.0 in Q4 2019 per RLMD's latest filing, from $255925.0 in the prior quarter.
- Across five years, Notes Payables topped out at $364204.0 in Q2 2019 and bottomed at $27583.0 in Q1 2017.
- The 5-year median for Notes Payables is $170418.0 (2015), against an average of $170744.5.
- The widest annual swing landed in 2015, when Notes Payables soared 352.05%; it then dropped 6.78% in 2016.
- Tracing RLMD's Notes Payables over 5 years: stood at $88533.0 in 2015, then gained by 24.25% to $110000.0 in 2016, then grew by 0.93% to $111020.0 in 2017, then increased by 3.31% to $114700.0 in 2018, then declined by 3.88% to $110247.0 in 2019.
- Per Business Quant, the three latest RLMD Notes Payables figures stand at $110247.0 (Q4 2019), $255925.0 (Q3 2019), and $364204.0 (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 110,247.00 |
| Sep 30, 2019 | 255,925.00 |
| Jun 30, 2019 | 364,204.00 |
| Mar 31, 2019 | 28,769.00 |
| Dec 31, 2018 | 114,700.00 |
| Sep 30, 2018 | 200,200.00 |
| Jun 30, 2018 | 285,170.00 |
| Mar 31, 2018 | 27,880.00 |
| Dec 31, 2017 | 111,020.00 |
| Sep 30, 2017 | 194,164.00 |
| Jun 30, 2017 | 276,700.00 |
| Mar 31, 2017 | 27,583.00 |
| Dec 31, 2016 | 110,000.00 |
| Sep 30, 2016 | 164,436.00 |
| Jun 30, 2016 | 273,670.00 |
| Dec 31, 2015 | 88,533.00 |
| Sep 30, 2015 | 176,400.00 |
| Jun 30, 2015 | 263,800.00 |
| Dec 31, 2014 | 38,088.00 |
| Sep 30, 2014 | 148,321.00 |
| Jun 30, 2014 | 58,357.00 |